Dr. Thanh Dellinger
View Contact Information
Schedule a Conversation with a HIPEC Surgeon
The surgeon or staff member will make their best effort to call you at your requested time. If they become unavailable you will receive a text.
Board Certified
Board certification by an ABMS Member Board is the premier, independently assessed credential attainable in medicine today.
Dr. Thanh Dellinger is affiliated with City of Hope.
Fellowship Experience
UC Irvine
Additional Information
Thanh Dellinger, M.D., is a gynecologic oncologist with specialized training in robotic-assisted (minimally invasive) surgery, advanced cytoreductive surgery for ovarian cancer, and in PIPAC, a novel drug delivery method for recurrent ovarian cancer patients. She currently leads the first in U.S. PIPAC clinical trial evaluating this novel therapy (NCT04329494.)
Dr. Dellinger’s research focus is in ovarian and uterine cancer, and she has co-authored over fifty papers on HIPEC, PIPAC, and novel therapies and molecular pathways in ovarian and uterine cancer. Her current clinical research focuses on optimizing PIPAC and HIPEC in ovarian cancer patients.
Dr. Dellinger received her medical degree at University of California Irvine, followed by a residency at Penn State University and a gynecologic oncology fellowship at University of California Irvine Medical Center.